{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:32:50Z","timestamp":1782711170403,"version":"3.54.5"},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4811","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:03:24Z","timestamp":1558609404000},"source":"Crossref","is-referenced-by-count":7,"title":["Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells"],"prefix":"10.3892","author":[{"given":"Shunsuke","family":"Kumanishi","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamanegi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishiura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nakasho","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Futani","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yoshiya","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"key20200713185856_b1-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/2211-5463.12428","article-title":"Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib","volume":"8","author":"Dai","year":"2018","journal-title":"FEBS Open Bio"},{"key":"key20200713185856_b2-ijo-55-01-0167","first-page":"8149","article-title":"MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1","volume":"15","author":"Qian","year":"2018","journal-title":"Oncol Lett"},{"key":"key20200713185856_b3-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat Genet"},{"key":"key20200713185856_b4-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng892","article-title":"A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer","volume":"31","author":"Suzuki","year":"2002","journal-title":"Nat Genet"},{"key":"key20200713185856_b5-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1475-2867-12-24","article-title":"Pathobiology of cancer metastasis: A short account","volume":"12","author":"Feller","year":"2012","journal-title":"Cancer Cell Int"},{"key":"key20200713185856_b6-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: Past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713185856_b7-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1158\/1535-7163.MCT-05-0417","article-title":"Angiostatic activity of DNA methyltransferase inhibitors","volume":"5","author":"Hellebrekers","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key20200713185856_b8-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.onc.1205108","article-title":"Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling","volume":"21","author":"Deroanne","year":"2002","journal-title":"Oncogene"},{"key":"key20200713185856_b9-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"key20200713185856_b10-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"68122","DOI":"10.18632\/oncotarget.11828","article-title":"Thrombomodulin promotes focal adhesion kinase activation and contributes to angiogenesis by binding to fibronectin","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713185856_b11-ijo-55-01-0167","first-page":"687","article-title":"Tumor angiogenesis and anti-angiogenic gene therapy for cancer","volume":"16","author":"Li","year":"2018","journal-title":"Oncol Lett"},{"key":"key20200713185856_b12-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0378-1119(97)00509-X","article-title":"Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells","volume":"204","author":"Tan","year":"1997","journal-title":"Gene"},{"key":"key20200713185856_b13-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1096\/fasebj.13.1.181","article-title":"VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo","volume":"13","author":"Zhai","year":"1999","journal-title":"FASEB J"},{"key":"key20200713185856_b14-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/384372a0","article-title":"A death-domain-containing receptor that mediates apoptosis","volume":"384","author":"Kitson","year":"1996","journal-title":"Nature"},{"key":"key20200713185856_b15-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"key20200713185856_b16-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.274.5289.990","article-title":"Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95","volume":"274","author":"Chinnaiyan","year":"1996","journal-title":"Science"},{"key":"key20200713185856_b17-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1073\/pnas.97.3.1230","article-title":"Overexpression of M68\/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster","volume":"97","author":"Bai","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185856_b18-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3892\/ijo.2015.2924","article-title":"Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells","volume":"46","author":"Yamanegi","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713185856_b19-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-\u0394\u0394C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713185856_b20-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713185856_b21-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1200\/JCO.2007.14.5730","article-title":"Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors","volume":"26","author":"Siu","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20200713185856_b22-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/1078-0432.CCR-07-0135","article-title":"Clinical and molecular responses in lung cancer patients receiving Romidepsin","volume":"14","author":"Schrump","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200713185856_b23-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2174\/13816128113199990527","article-title":"Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells","volume":"20","author":"Xu","year":"2014","journal-title":"Curr Pharm Des"},{"key":"key20200713185856_b24-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2867-6-2","article-title":"Antineoplastic effects of the DNA meth-ylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines","volume":"6","author":"Chavez-Blanco","year":"2006","journal-title":"Cancer Cell Int"},{"key":"key20200713185856_b25-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tranon.2014.03.001","article-title":"A phase I protocol of hydralazine and valproic acid in advanced, previously treated solid cancers","volume":"7","author":"Bauman","year":"2014","journal-title":"Transl Oncol"},{"key":"key20200713185856_b26-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"e95596","DOI":"10.1371\/journal.pone.0095596","article-title":"Separate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell line","volume":"9","author":"Capobianco","year":"2014","journal-title":"PLoS One"},{"key":"key20200713185856_b27-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/art.21637","article-title":"Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells","volume":"54","author":"Takami","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20200713185856_b28-ijo-55-01-0167","first-page":"572","article-title":"Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis","volume":"6","author":"Kaya","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20200713185856_b29-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1177\/147323001103900436","article-title":"Difference in pre- and postchemotherapy vascular endothelial growth factor levels as a prognostic indicator in osteosarcoma","volume":"39","author":"Qu","year":"2011","journal-title":"J Int Med Res"},{"key":"key20200713185856_b30-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.21873\/anticanres.11077","article-title":"Valproic acid alters angiogenic and trophic gene expression in human prostate cancer models","volume":"36","author":"Chelluri","year":"2016","journal-title":"Anticancer Res"},{"key":"key20200713185856_b31-ijo-55-01-0167","doi-asserted-by":"crossref","first-page":"56110","DOI":"10.18632\/oncotarget.18125","article-title":"Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185856_b32-ijo-55-01-0167","first-page":"97","article-title":"Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: Enhancement by combination with interferon-alpha","volume":"20","author":"Cinatl","year":"2002","journal-title":"Int J Oncol"},{"key":"key20200713185856_b33-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1096\/fj.201600800R","article-title":"TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation","volume":"31","author":"Yang","year":"2017","journal-title":"FASEB J"},{"key":"key20200713185856_b34-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"13863","DOI":"10.1073\/pnas.1304529110","article-title":"TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1","volume":"110","author":"Qi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185856_b35-ijo-55-01-0167","doi-asserted-by":"crossref","first-page":"69436","DOI":"10.18632\/oncotarget.11683","article-title":"TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713185856_b36-ijo-55-01-0167","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/2211-5463.12171","article-title":"Vascular endothelial growth factor suppresses TNFSF15 production in endothelial cells by stimulating miR-31 and miR-20a expression via activation of Akt and Erk signals","volume":"7","author":"Deng","year":"2016","journal-title":"FEBS Open Bio"},{"key":"key20200713185856_b37-ijo-55-01-0167","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: Indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"key20200713185856_b38-ijo-55-01-0167","first-page":"CD004934","article-title":"Hydralazine for essential hypertension","volume":"8","author":"Kandler","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T13:56:09Z","timestamp":1721310969000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4811","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}